118 related articles for article (PubMed ID: 7575356)
1. Antagonistic mutant proteins of interleukin-4.
Duschl A; Müller T; Sebald W
Behring Inst Mitt; 1995 Jun; (96):87-94. PubMed ID: 7575356
[TBL] [Abstract][Full Text] [Related]
2. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
3. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the human IgE response.
de Vries JE; Yssel H
Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
[TBL] [Abstract][Full Text] [Related]
5. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
Jerva LF; Sullivan G; Lolis E
Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of human IL-13 and implication for receptor binding.
Moy FJ; Diblasio E; Wilhelm J; Powers R
J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
[TBL] [Abstract][Full Text] [Related]
7. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.
Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A
J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109
[TBL] [Abstract][Full Text] [Related]
8. Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy.
Müller T; Dieckmann T; Sebald W; Oschkinat H
J Mol Biol; 1994 Apr; 237(4):423-36. PubMed ID: 8151703
[TBL] [Abstract][Full Text] [Related]
9. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
[TBL] [Abstract][Full Text] [Related]
10. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
11. A model of the complex between interleukin-4 and its receptors.
Gustchina A; Zdanov A; Schalk-Hihi C; Wlodawer A
Proteins; 1995 Feb; 21(2):140-8. PubMed ID: 7777489
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of interleukin-13 and insights into receptor engagement.
Eisenmesser EZ; Horita DA; Altieri AS; Byrd RA
J Mol Biol; 2001 Jun; 310(1):231-41. PubMed ID: 11419949
[TBL] [Abstract][Full Text] [Related]
13. Cytokine recognition by human interleukin 5 receptor.
Ishino T; Robertson N; Chaiken I
Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273
[TBL] [Abstract][Full Text] [Related]
14. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
[TBL] [Abstract][Full Text] [Related]
15. Expression of a functional IL-13Ralpha1 by rat B cells.
Pierrot C; Beniguel L; Bègue A; Khalife J
Biochem Biophys Res Commun; 2001 Oct; 287(4):969-76. PubMed ID: 11573960
[TBL] [Abstract][Full Text] [Related]
16. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
17. Biology of natural and recombinant soluble interleukin-4 receptor.
Enssle K; Enders B; Kurrle R; Lauffer L; Schorlemmer HU; Dickneite G; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1995 Jun; (96):103-17. PubMed ID: 7575346
[No Abstract] [Full Text] [Related]
18. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
[TBL] [Abstract][Full Text] [Related]
19. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential.
Lauffer L; Kanzy EJ; Köhler R; Kurrle R; Enssle K; Seiler FR
Behring Inst Mitt; 1995 Jun; (96):21-31. PubMed ID: 7575349
[TBL] [Abstract][Full Text] [Related]
20. Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
Mueller TD; Zhang JL; Sebald W; Duschl A
Biochim Biophys Acta; 2002 Nov; 1592(3):237-50. PubMed ID: 12421669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
